A股異動丨永興材料(002756.SZ)漲近6% 與寧德時代擬成立合資公司 共同投建碳酸鋰項目
格隆匯1月27日丨永興材料(002756.SZ)漲近6%,報123.08元,總市值500億元。永興材料公佈,公司於1月26日召開了第五屆董事會第十八次臨時會議,審議通過了《關於與寧德時代新能源科技股份有限公司簽署合資經營協議的議案》,同意公司與寧德時代新能源科技股份有限公司簽署《合資經營協議》。為有效整合雙方優勢,公司與寧德時代擬成立合資公司,共同投資建設碳酸鋰項目,並開展相關產品領域合作,充分發揮公司在雲母提鋰方面的技術、管理優勢及雲母提鋰行業龍頭地位優勢,提高國內鋰資源的保障能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.